{"id":"W2123158115","doi":"10.1158/1078-0432.ccr-06-1863","title":"Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Advanced Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":212,"is_retracted":false,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada)","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Medicine; Dosing; Nausea; Pharmacokinetics; Pharmacodynamics; Toxicity; Adverse effect; Tolerability; Pharmacology; Internal medicine; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003141174,0.0001634276,0.0003664894,0.0001322014,0.00005780557,0.00001225109,0.0003513609,0.0002505746,0.0001506534],"category_scores_gemma":[0.0001953916,0.0001367175,0.00011965,0.0003897484,0.000274679,0.000006194227,0.0001485596,0.0004815421,0.000001577427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008745882,"about_ca_system_score_gemma":0.0005410351,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003205255,"about_ca_topic_score_gemma":0.002856604,"domain_scores_codex":[0.9973483,0.0002114048,0.0006870439,0.000572425,0.0005748924,0.0006058991],"domain_scores_gemma":[0.9984669,0.0001664502,0.0001581415,0.0005012062,0.0005087726,0.0001985471],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3199419,0.004783577,0.02242143,0.00006919043,0.0002566349,0.00001214363,0.00009841011,0.0000912718,0.07423797,0.0001538792,0.002548967,0.5753846],"study_design_scores_gemma":[0.4475548,0.04786097,0.04363848,0.0003337951,0.00008504049,6.010351e-7,0.0002255746,0.00005487209,0.2472396,0.0004705708,0.2115992,0.0009365092],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958869,0.001214754,0.0005189434,0.0001635829,0.0004001325,0.0009303127,0.00007033392,0.000005523159,0.0008094689],"genre_scores_gemma":[0.9957701,0.001678071,0.0004405224,0.0002982896,0.0005219382,0.000162613,0.00004493429,0.00003818813,0.001045348],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5744481,"threshold_uncertainty_score":0.5575176,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.13591248393524,"score_gpt":0.5333629320324956,"score_spread":0.3974504480972556,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}